U.S. Heparin Market Size & Outlook, 2023-2030
U.S. heparin market, 2018-2030 (US$M)
Related Markets
U.S. heparin market highlights
- The U.S. heparin market generated a revenue of USD 2,605.6 million in 2023 and is expected to reach USD 2,927.2 million by 2030.
- The U.S. market is expected to grow at a CAGR of 1.7% from 2024 to 2030.
- In terms of segment, porcine was the largest revenue generating source in 2023.
- Bovine is the most lucrative source segment registering the fastest growth during the forecast period.
Heparin market data book summary
| Market revenue in 2023 | USD 2,605.6 million |
| Market revenue in 2030 | USD 2,927.2 million |
| Growth rate | 1.7% (CAGR from 2023 to 2030) |
| Largest segment | Porcine |
| Fastest growing segment | Bovine |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Porcine, Bovine |
| Key market players worldwide | Pfizer Inc, Sanofi SA, Aspen Pharmacare Holdings Ltd, Fresenius SE & Co KGaA, Novartis AG ADR, GSK PLC ADR, Dr. Reddy’s Laboratories, LEO Pharma, B. Braun Medical |
Other key industry trends
- In terms of revenue, U.S. accounted for 35.2% of the global heparin market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. heparin market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 396.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Heparin Market Scope
Heparin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. heparin market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to heparin market will help companies and investors design strategic landscapes.
Porcine was the largest segment with a revenue share of 89.57% in 2023. Horizon Databook has segmented the U.S. heparin market based on porcine, bovine covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. held the largest share in North America’s heparin market in 2019, due to high prevalence of chronic diseases and rise in healthcare expenditure. According to a study published in the American Heart Association, in 2019, 1 in 4 deaths were observed in the U.S. due to heart diseases, which was marked as one of the major causes of deaths in the country.
According to the ACC/AHA Guideline for the Prevention Detection, Evaluation, and Management of High Blood Pressure, in 2017, around 45.6% of U.S. adults had hypertension. Nearly 10 to 12 million heart attack patients in the U.S. are prescribed heparin annually to prevent blood clots.
The population of people over 65 is estimated to rise from 16% in 2018 to 23% in 2060. this demographic is at a higher risk of diseases such as pulmonary embolism, ischemic stroke, and Deep Vein Thrombosis (DVT).
Reasons to subscribe to U.S. heparin market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. heparin market databook
-
Our clientele includes a mix of heparin market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. heparin market , including forecasts for subscribers. This country databook contains high-level insights into U.S. heparin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. heparin market size, by source, 2018-2030 (US$M)
U.S. Heparin Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
